Serena R.
- Country
- Italy
- Department
- 3107: SOD Clinica Ematologica
Research Overview
- Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL
- Evaluation of Navtemadlin Versus Best Available Therapy in Myelofibrosis Patients Refractory to JAK Inhibitors
- Evaluation of Sulodexide for the Prevention of Recurrent Venous Thromboembolism in Elderly Patients Post-First Episode of Deep Vein Thrombosis or Pulmonary Embolism
Data & Insights
Has run more than one trial at 17 of 109 partner sites.
Specializations
Thrombosis Research
Specializes in the prevention and treatment of venous thromboembolism (VTE), with particular focus on elderly patients who have experienced deep vein thrombosis or pulmonary embolism.
- Deep Vein Thrombosis Prevention
- Pulmonary Embolism Management
- Geriatric Thrombosis Care
Investigates novel therapeutic approaches using anticoagulant medications for preventing VTE recurrence.
Hematologic Disorders
Conducts research in various blood disorders including Essential Thrombocythemia and Polycythemia Vera, focusing on patients who require alternative treatment options.
- JAK2V617F-positive Conditions
- Treatment-Resistant Cases
- Novel Therapeutic Approaches
Explores innovative treatments for patients who show inadequate response to conventional therapies.
Myelofibrosis Research
Specializes in both primary and secondary myelofibrosis, with expertise in treating cases resistant to standard therapies.
- Post-PV Myelofibrosis
- Post-ET Myelofibrosis
- JAK Inhibitor-Resistant Cases
Focuses on developing treatment strategies for patients with advanced myeloproliferative disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.